The madigan army medical center (MAMC) department of pathology requires a replacement equipment lease contract for two multiplex molecular analyzer systems and the supply of testing panel reagents…

Active Indefinite Delivery Contract Awarded Last action

Contract number
W81K0225DA010
Awardee
Awarding agency
Task orders
2 $968,332 obligated

Award facts

Opportunity
Combined order value
$1,936,663 Current and potential, with all options
Last date to order 22% complete
IDV ceiling 20% used
$4,853,244.74
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Health Agency awarded an indefinite-delivery contract to Biofire Defense LLC on October 1, 2025, for equipment lease of two multiplex molecular analyzer systems and testing panel reagents, with a contract ceiling of $4,853,244.74 and a performance period extending through September 30, 2030. This is a single-award contract with no set-aside.

Work is performed at Lewis-McChord, Washington 98431, supporting the Madigan Army Medical Center Department of Pathology. The originating market research, posted May 8, 2025, sought systems capable of multiplexed nucleic acid testing with results within 90 minutes, supporting random-access analysis of at least four specimens across blood cultures, respiratory samples, cerebrospinal fluid, and bio-threat agents. The analyzer must interface with the military hospital's Anatomic Pathology Laboratory Information System and include proactive instrument-parameter monitoring. NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC 6550 (in vitro diagnostic substances, reagents, test kits, and sets) apply.

A delivery order issued October 1, 2025, under this IDIQ carries a ceiling of $968,331.59 and completion date of September 30, 2026, for equipment lease and reagent supply at the same location. The delivery order is priced firm fixed price with no set-aside.

Description

The madigan army medical center (MAMC) department of pathology requires a replacement equipment lease contract for two multiplex molecular analyzer systems and the supply of testing panel reagents to maintain timely laboratory testing capabilities.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 · The madigan army medical center department of pathology requires a replacement equipment lease contract for two multiplex molecular analyzer systems and the… $0
Other Administrative Action P00002 · Multiplex molecular analyzer systems and the supply of testing panel reagents $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract W81K0225DA010?

W81K0225DA010 was awarded to Biofire Defense LLC by Defense Health Agency (Department of Defense) on October 1, 2025.

How much is contract W81K0225DA010 worth?

Orders under W81K0225DA010 have obligated $968,332. Their combined current value, with exercised options, is $1,936,663. W81K0225DA010's own ceiling is $4,853,245.

How many orders have been placed under contract W81K0225DA010?

2 orders have been placed under W81K0225DA010, the latest on October 1, 2026.

Who can order from contract W81K0225DA010?

W81K0225DA010 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0225DA010 competed?

The extent of competition for W81K0225DA010 was not competed under sap. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV